Skip to main content
. 2006 Aug 11;92(2):142–146. doi: 10.1136/adc.2006.101642

Table 3 Secondary outcomes by spacer group.

Outcome Bottle Conventional p Value
Need for systemic corticosteroids (n, %) 41 (20.5%) 37 (18.5%) 0.61
Change in clinical score (median, IQR) −2 (−3 to −1) −2 (−3 to −1) 0.53
Change in oxygen saturation (median, IQR) 0 (−1 to 1) 0 (−1 to 1) 0.53
Number of bronchodilator treatments (median, IQR) 2 (1 to 3) 2 (1 to 3) 0.67